Efthymios N. Deliargyris

Overview

Efthymios N. Deliargyris received an average of $1M in total compensation, including $369K in salary, at Cytosorbents from 2020 to 2023.

Source: SEC filings on April 19, 2024, April 21, 2023, and April 22, 2022.

Related executives

We found six more executives who work or worked at Cytosorbents.

Phillip Chan

Cytosorbents

Chief Executive Officer

Vincent Capponi

Cytosorbents

Chief Operating Officer

Kathleen Bloch

Cytosorbents

Chief Financial Officer

Eric Mortensen

Cytosorbents

Chief Medical Officer

Robert Bartlett

Cytosorbents

Chief Medical Officer

Ronald Berger

Cytosorbents

Chief Financial Officer

News

You may also like